About this Medicine article

Updated Clinical Classification of Pulmonary Hypertension by Gerald Simonneau; Michael A. Gatzoulis; Ian Adatia; David Celermajer; Chris Denton; Ardeschir Ghofrani; Miguel Angel Gomez Sanchez; R. Krishna Kumar; Michael Landzberg; Roberto F. Machado; Horst Olschewski; Ivan M. Robbins; Rogiero Souza is a Medicine article available to read on EtoBox.

In 1998, a clinical classification of pulmonary hypertension (PH) was established, categorizing PH into groups which share similar pathological and hemodynamic characteristics and therapeutic approaches. During the 5th World Symposium held in Nice, France, in 2013, the consensus was reached to maintain the general scheme of previous clinical classifications. However, modifications and updates especially for Group 1 patients (pulmonary arterial hypertension [PAH]) were proposed. The main change was to withdraw persistent pulmonary hypertension of the newborn (PPHN) from Group 1 because this entity carries more differences than similarities with other PAH subgroups. In the current classification, PPHN is now designated number 1. Pulmonary hypertension associated with chronic hemolytic anemia has been moved from Group 1 PAH to Group 5, unclear/multifactorial mechanism. In addition, it was decided to add specific items related to pediatric pulmonary hypertension in order to create a comprehensive, common classification for both adults and children. Therefore, congenital or acquired left-heart inflow/outflow obstructive lesions and congenital cardiomyopathies have been added to Group 2,

Author

Gerald Simonneau; Michael A. Gatzoulis; Ian Adatia; David Celermajer; Chris Denton; Ardeschir Ghofrani; Miguel Angel Gomez Sanchez; R. Krishna Kumar; Michael Landzberg; Roberto F. Machado; Horst Olschewski; Ivan M. Robbins; Rogiero Souza

Publisher

Elsevier BV

Published

2013

Language

EN

Field

Medicine (Health Sciences)